New lenses to look at preeclampsia

References

• Berg CJ, Callaghan WM, Syverson C, Henderson Z. Pregnancy-related mortality in the United States 1998 to 2005. Obstet Gynecol 2010;116:1302–9
   PubMed Web of Science ®Google Scholar
• Roberts JM, Pearson G, Cutler J, Lindheimer M. Summary of the NHLBI working group on research on hypertension in pregnancy. Hypertension 2003;41:437–45
   PubMed Web of Science ®Google Scholar
• Hypertension in Pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013;122
   Web of Science ®Google Scholar
• Hypertension in pregnancy. The management of hypertensive disorders during pregnancy Issued: August 2010, last modified: January 2011. NICE clinical guideline 107
   Google Scholar
• Kuklina EV, Ayala C, Callaghan WM. Hypertensive disorders and severe obstetric morbidity in the United States. Obstet Gynecol 2009;113:1299–306
   PubMed Web of Science ®Google Scholar
• Hypertensive disorders in pregnancy, Guideline summary. New York State Department of Health, May 2013
   Google Scholar
• Lowe SA, Bowyer L, Lust K, et al. The SOMANZ guideline for the management of hypertensive disorders of pregnancy. 2014
   Google Scholar
• Magee LA, Pels A, Helewa M, et al. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. J Obstet Gynaecol Can 2014;29:416–38
   Google Scholar
• Ferrazzi E, Stampalija T, Aupont J. The evidence for late-onset pre-eclampsia as a maternogenic disease of pregnancy. Fetal Matern Med Rev 2013;24:18–31
   Google Scholar
• Steegers AE, von Dadelszen P, Duvekot JJ, Pijnenborg R. Seminar, preeclampsia. Lancet 2010;376:631–44
   PubMed Web of Science ®Google Scholar
• Khan KS, Wojdyla D, Say L, et al. WHO analysis of causes of maternal death: a systematic review. Lancet 2006;367:1066–74
   PubMed Web of Science ®Google Scholar
• Myatt L, Redman CW, Staff AC, et al. Strategy for standardization of pre-eclampsia research study design. Hypertension 2014;63:1293–301
   PubMed Web of Science ®Google Scholar
• Roberts JM. Objective evidence of endothelial dysfunction in preeclampsia. Am J Kidney Dis 1999;33:992–7
   PubMed Web of Science ®Google Scholar
• Baschat AA. First-trimester screening for pre-eclampsia: moving from personalized risk prediction to prevention. Ultrasound Obstet Gynecol 2015;45:119–29
   PubMed Web of Science ®Google Scholar
• Kusanovic JP, Romero R, Chaiworapongsa T, et al. A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia. J Matern Fetal Neonatal Med 2009;22:1021–38
   PubMed Web of Science ®Google Scholar
• Stampalija T, Chaiworapongsa T, Romero R, et al. Maternal plasma concentrations of sST2 and angiogenic/anti-angiogenic factors in pre-eclampsia. J Matern Fetal Neonatal Med 2013;26:1359–70
   PubMed Web of Science ®Google Scholar
• Chappell LC, Duckworth S, Seed PT, et al. Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study. Circulation 2013;128:2121–31
   PubMed Web of Science ®Google Scholar
• Akolekar R, Syngelaki A, Poon L, et al. Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn Ther 2013;33:8–15
   PubMed Web of Science ®Google Scholar
• Rana S, Karumanchi SA, Lindheimer MD. Angiogenic factors in diagnosis, management, and research in preeclampsia. Hypertension 2014;63:198–202
   PubMed Web of Science ®Google Scholar
• Redman CW, Sargent IL, Staff AC. IFPA Senior Award Lecture: making sense of pre-eclampsia – two placental causes of preeclampsia? Placenta 2014;35:S20–5
   PubMed Web of Science ®Google Scholar
• Staff AC, Redman CW. IFPA Award in Placentology Lecture: preeclampsia, the decidual battleground and future maternal cardiovascular disease. Placenta 2014;35:S26–31
   PubMed Web of Science ®Google Scholar
• Roberts JM, Hubel CA. The two stage model of preeclampsia: variations on the theme. Placenta 2009;30:32–7
   PubMed Web of Science ®Google Scholar
• Redline RW. Placental pathology: a systematic approach with clinical correlations. Placenta 2008;29:S86–91
   PubMed Web of Science ®Google Scholar
• Mayhew TM, Ohadike C, Baker PN, et al. Stereological investigation of placental morphology in pregnancies complicated by pre-eclampsia with and without intrauterine growth restriction. Placenta 2003;24:219–26
   PubMed Web of Science ®Google Scholar
• Egbor M, Ansari T, Morris N, et al. Maternal medicine: morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction. BJOG 2006;113:580–9
   PubMed Web of Science ®Google Scholar
• Valensise H, Vasapollo B, Gagliardi G, Novelli GP. Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension 2008;52:873–80
   PubMed Web of Science ®Google Scholar
• Melchiorre K, Sutherland G, Sharma R, et al. Mid-gestational maternal cardiovascular profile in preterm and term pre-eclampsia: a prospective study. BJOG 2013;120:496–504
   PubMed Web of Science ®Google Scholar
• Oliveira N, Magder LS, Blitzer MG, Baschat AA. First-trimester prediction of pre-eclampsia: external validity of algorithms in a prospectively enrolled cohort. Ultrasound Obstet Gynecol 2014;44:279–85
   PubMed Web of Science ®Google Scholar
• Stampalija T, Quadrifoglio M, Di Martino D, et al. Differentiation of clinical phenotypes of hypertensive disorders in pregnancy by first trimester uterine artery Doppler velocimetry. Submitted for publication
   Google Scholar
• Schwartz N, Coletta J, Pessel C, et al. Novel 3-dimensional placental measurements in early pregnancy as predictors of adverse pregnancy outcomes. J Ultrasound Med 2010;29:1203–12
   PubMed Web of Science ®Google Scholar
• Borzychowski AM, Sargent IL, Redman CWG. Inflammation and pre-eclampsia. Semin Fetal Neonatal Med 2006;11:309–16
   PubMed Web of Science ®Google Scholar
• Burton GJ, Woods AW, Jauniaux E, Kingdom JC. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta 2010;30:473–82
   Web of Science ®Google Scholar
• Ferrazzi E, Zullino S, Stampalija T, et al. Bedside diagnosis of two major clinical phenotypes of hypertensive disorders of pregnancy. Ultrasound Obstet Gynecol 2015. [Epub ahead of print]. doi:10.1002/uog.15741
   Google Scholar
• Valensise H, Vasapollo B, Novelli GP, et al. Maternal and fetal hemodynamic effects induced by nitric oxide donors and plasma volume expansion in pregnancies with gestational hypertension complicated by intrauterine growth restriction with absent end-diastolic flow in the umbilical artery. Ultrasound Obstet Gynecol 2008;31:55–64
   PubMed Web of Science ®Google Scholar
• Ferrazzi E, Muggiasca M, Gervasi MT. Low molecular weight heparin: does it represent a clinical opportunity for preventing preeclampsia associated with fetal growth restriction? J Matern Fetal Neonatal Med 2015;28:1525–9
   PubMed Web of Science ®Google Scholar
• Dodd JM, McLeod A, Windrim RC, Kingdom J. Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction. Cochrane Database Syst Rev 2013;1:1–51
   Google Scholar
• Rodger MA, Carrier M, Le Gal G, et al. Meta-analysis of low-molecular-weight heparin to prevent recurrent placenta-mediated pregnancy complications. Blood 2014;123:822–8
   PubMed Web of Science ®Google Scholar
• Martinelli I, Ruggenenti P, Cetin I, et al. Heparin in pregnant women with previous placenta-mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial. Blood 2012;119:3269–75
   PubMed Web of Science ®Google Scholar
• Conserva V, Muggiasca M, Arrigoni L, et al. Recurrence and severity of abnormal pregnancy outcome in patients treated by low-molecular-weight heparin: a prospective pilot study. J Mater Fetal Neonatal Med 2012;25:1467–73
   PubMed Web of Science ®Google Scholar
• Bujold E, Roberge S, Lacasse Y, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 2010;116:402–14
   PubMed Web of Science ®Google Scholar
• Askie LM, Duley L, Henderson-Smart DJ, et al. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 2007;369:1791–8
   PubMed Web of Science ®Google Scholar
• Verlohren S, Melchiorre K, Khalil A, Thilaganathan B. Uterine artery Doppler, birth weight and timing of onset of pre-eclampsia: providing insights into the dual etiology of late-onset pre-eclampsia. Ultrasound Obstet Gynecol 2014;44:293–8
   PubMed Web of Science ®Google Scholar
• Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672–83
   PubMed Web of Science ®Google Scholar